Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Thymalin and Vilon Interaction: Synergistic | Peptide Database

Compound Profiles Thymalin Thymic Peptide Bioregulator | Immune Modulator Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates d

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Thymalin

Thymic Peptide Bioregulator | Immune Modulator

Thymalin's immunoprotective action stems from short peptides (KE, EW, EDP) that specifically bind to double-stranded DNA and histone proteins to regulate gene expression. It stimulates differentiation and activity of T-lymphocytes, especially CD4+ and CD8+ cells, promotes cytokine regulation, enhances antigen response, and stimulates stem cell differentiation.

Vilon

KE Dipeptide | Thymus Immune Bioregulator

Vilon works through epigenetic modulation, restoring chromatin structure and gene expression in immune cells. It stimulates thymocyte proliferation, activates T-helper cells, and increases the proliferative index in thymus tissue (from 26% to 37% in studies).

Shared Safety Flags

Frequently Asked Questions

Can I take Thymalin with Vilon?

Yes, Thymalin and Vilon can generally be taken together. Often used together for enhanced systemic recovery and immune support.

Is Thymalin and Vilon safe together?

Based on documented research, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.

What are the interactions between Thymalin and Vilon?

Often used together for enhanced systemic recovery and immune support. This assessment has 95% confidence and is based on documented research data.

How should I time Thymalin and Vilon?

Thymalin has a half-life of Not established (complex mixture); effects persist for weeks and Vilon has a half-life of Not established. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the ideal 5/5 vs 10/3 ratio for Tesa/IPA and when to use each?

5/5 (equal parts) provides balanced GH stimulation suitable for general recovery. The 10/3 (higher tesamorelin) variant emphasizes visceral fat loss and metabolic effects. Choose 5/5 for at…

Source: peptide-db.com
comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

Currently in Phase 2 clinical trials for the treatment of androgenetic alopecia. Phase 2a results showed measurable increases in hair count and thickness with the 0.05% topical gel formulation. PP405 directly targets metabolic dormancy in hair follicle stem cells by inhibiting MPC1/MPC2 and promoting anagen re-entry. This mechanism may address follicle miniaturization at an earlier stage than androgen-blocking approaches.

Source: peptide-db.com ↗

Why does 2024 research show BAM-15 works better with semaglutide?

Combining BAM-15 (mitochondrial uncoupler) with semaglutide (GLP-1 agonist) produces stronger metabolic benefits than either alone by countering metabolic adaptation. Semaglutide's appetite suppression plateaus as the body adapts; BAM-15's energy expenditure boost prevents this adaptation, allowing sustained weight loss.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Primary administration route with well-established protocols for direct brain delivery via IV/IM. Small Volume IV Up to 10mL Once daily Undiluted IV slow push over 3 minutes Intramuscular Up to 5mL Undiluted IM injection over 3 minutes Acute Stroke 20-50mL Once daily for 10-21 days IV infusion (diluted to 100mL minimum) Traumatic Brain Injury Once daily for 7-30 days Alzheimer's Disease 10-30mL 5 days weekly for 4 weeks IV injection/infusion (2-4 cycles yearly) Vascular Dementia

Source: peptide-db.com ↗
Side effects

Common Side Effects

Liver stress and enzyme elevation (ALT, AST) due to 17-alpha alkylated steroidal structure Testosterone suppression (dose- and duration-dependent, expected in all users) Joint dryness and discomfort (related to reduced estrogenic activity and potential drying effect) Hair shedding (consistent with androgenic activity from the DHT-derived structure; may or may not be reversible) Lipid disruption (HDL suppression, LDL elevation) Reduced libido and mood changes secondary to hormonal suppression Mild headaches, particularly during the first week

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →